Kurahara H - Search Results

1

Implications of PD-1, Tim-3, and TIGIT Expression for Cancer Immunity and Pancreatic Cancer Prognosis.

Nakayama C, Tanoue K, Idichi T, Shimomura H, Kita Y, Hozaka Y, Shinden Y, Matsushita D, Nakajo A, Arigami T, Mataki Y, Kurahara H, Ohtsuka T. Nakayama C, et al. Among authors: kurahara h. Anticancer Res. 2022 Jul;42(7):3373-3380. doi: 10.21873/anticanres.15824. Anticancer Res. 2022. PMID: 35790289

2

Clinical significance of midkine expression in pancreatic head carcinoma.

Maeda S, Shinchi H, Kurahara H, Mataki Y, Noma H, Maemura K, Aridome K, Yokomine T, Natsugoe S, Aikou T, Takao S. Maeda S, et al. Among authors: kurahara h. Br J Cancer. 2007 Aug 6;97(3):405-11. doi: 10.1038/sj.bjc.6603879. Epub 2007 Jul 10. Br J Cancer. 2007. PMID: 17622248 Free PMC article.

3

CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer.

Maeda S, Shinchi H, Kurahara H, Mataki Y, Maemura K, Sato M, Natsugoe S, Aikou T, Takao S. Maeda S, et al. Among authors: kurahara h. Br J Cancer. 2008 Apr 22;98(8):1389-97. doi: 10.1038/sj.bjc.6604307. Epub 2008 Mar 18. Br J Cancer. 2008. PMID: 18349830 Free PMC article.

4

Comparison of hyper-fractionated accelerated and standard fractionated radiotherapy with concomitant low-dose gemcitabine for unresectable pancreatic cancer.

Maemura K, Shinchi H, Noma H, Mataki Y, Kurahara H, Maeda S, Hiraki Y, Nakajo M, Natsugoe S, Takao S. Maemura K, et al. Among authors: kurahara h. Anticancer Res. 2008 Jul-Aug;28(4C):2369-72. Anticancer Res. 2008. PMID: 18751420 Free article. Clinical Trial.

5

Strong Smad4 expression correlates with poor prognosis after surgery in patients with hepatocellular carcinoma.

Hiwatashi K, Ueno S, Sakoda M, Kubo F, Tateno T, Kurahara H, Mataki Y, Maemura K, Ishigami S, Shinchi H, Natsugoe S. Hiwatashi K, et al. Among authors: kurahara h. Ann Surg Oncol. 2009 Nov;16(11):3176-82. doi: 10.1245/s10434-009-0614-2. Epub 2009 Jul 21. Ann Surg Oncol. 2009. PMID: 19626374

6

Significance of M2-polarized tumor-associated macrophage in pancreatic cancer.

Kurahara H, Shinchi H, Mataki Y, Maemura K, Noma H, Kubo F, Sakoda M, Ueno S, Natsugoe S, Takao S. Kurahara H, et al. J Surg Res. 2011 May 15;167(2):e211-9. doi: 10.1016/j.jss.2009.05.026. Epub 2009 Jun 16. J Surg Res. 2011. PMID: 19765725

7

[Clinical usefulness of FDG-PET for pancreatic cancer].

Mataki Y, Shinchi H, Kurahara H, Maemura K, Noma H, Natsugoe S, Takao S. Mataki Y, et al. Among authors: kurahara h. Gan To Kagaku Ryoho. 2009 Dec;36(13):2516-20. Gan To Kagaku Ryoho. 2009. PMID: 20009449 Japanese.

8

Asymptomatic somatostatinoma of the pancreatic head: Report of a case.

Arima H, Natsugoe S, Maemura K, Hata Y, Kumanohoso T, Imamura H, Mataki Y, Kurahara H, Shinchi H, Takao S, Aikou T. Arima H, et al. Among authors: kurahara h. Surg Today. 2010 Jun;40(6):569-73. doi: 10.1007/s00595-008-4089-8. Epub 2010 May 23. Surg Today. 2010. PMID: 20496141

9

[Combination chemotherapy resulting in complete response of huge lymph node metastases in undifferentiated gastric cancer--case report].

Megumi K, Ishigami S, Yanagita S, Arigami T, Uenosono Y, Kurahara H, Maemura K, Shinchi H, Hokita S, Ueno S, Natsugoe S. Megumi K, et al. Among authors: kurahara h. Gan To Kagaku Ryoho. 2010 Jul;37(7):1373-6. Gan To Kagaku Ryoho. 2010. PMID: 20647730 Japanese.

10

Prognostic impact of CD133 expression in gastric carcinoma.

Ishigami S, Ueno S, Arigami T, Uchikado Y, Setoyama T, Arima H, Kita Y, Kurahara H, Okumura H, Matsumoto M, Kijima Y, Natsugoe S. Ishigami S, et al. Among authors: kurahara h. Anticancer Res. 2010 Jun;30(6):2453-7. Anticancer Res. 2010. PMID: 20651407

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

204 results

Search Page